Plaque complement activation and cognitive loss in Alzheimer's disease

This publication has 46 references indexed in Scilit:

• Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
  Nature Biotechnology, 2007
• Experience-Dependent Sharpening of Visual Shape Selectivity in Inferior Temporal Cortex
  Cerebral Cortex, 2005
• Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people
  Journal of Neurology, Neurosurgery & Psychiatry, 2005
• Identifying severely atrophic cortical subregions in Alzheimer's disease
  Neurobiology of Aging, 2003
• Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress 1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
  Free Radical Biology & Medicine, 2002
• Complement activation by the amyloid proteins Aβ peptide and β₂-microglobulin
  Amyloid, 1999
• Multivalent Binding of Complement Protein C1q to the Amyloid β-Peptide (Aβ) Promotes the Nucleation Phase of Aβ Aggregation
  Biochemical and Biophysical Research Communications, 1995
• Enhanced cytotoxicity of amyloid β-peptide by a complement dependent mechanism
  Neuroscience Letters, 1994
• Pathological Proteins in Senile Plaques.
  The Tohoku Journal of Experimental Medicine, 1994
• Neuropathological stageing of Alzheimer-related changes
  Acta Neuropathologica, 1991